GlobeNewswire Inc | Jul 6, 2021 02:15PM EDT

July 06, 2021

OCALA, Fla., July 06, 2021 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) today announced that it will host an investor update webcast at 11:00 a.m. Eastern Time on Wednesday, July 14, 2021, to discuss recent accomplishments and upcoming milestones. Investors and other interested parties are invited to submit questions to management prior to the call's start via email to aim@crescendo-ir.com.

The webcast may be accessed at https://www.webcaster4.com/Webcast/Page/2605/41875 or on the Companys website at https://aimimmuno.com/events-presentations/. For those unable to participate at that time, a replay of the webcast will be available until Thursday, July 14, 2022 on the Companys website.

About AIM ImmunoTech Inc.

AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases, including COVID-19, the disease caused by the SARS-CoV-2 virus.

Contacts:

Crescendo Communications, LLCPhone: 212-671-1021Email:aim@crescendo-ir.com

AIM ImmunoTech IncPhone: 800-778-4042Email:IR@aimimmuno.com